title: Radiobiological considerations of total body irradiation in bone marrow transplant conditioning: hyperfractionation of dose and early results.
authors.forename: P
authors.initials: P
authors.lastname: Latini
authors.forename: F
authors.initials: F
authors.lastname: Checcaglini
authors.forename: E
authors.initials: E
authors.lastname: Maranzano
authors.forename: B M
authors.initials: BM
authors.lastname: Panizza
authors.forename: C
authors.initials: C
authors.lastname: Aristei
authors.forename: C
authors.initials: C
authors.lastname: Raymondi
authors.forename: E
authors.initials: E
authors.lastname: Perrucci
authors.forename: G
authors.initials: G
authors.lastname: Gobbi
authors.forename: F
authors.initials: F
authors.lastname: Aversa
authors.forename: M F
authors.initials: MF
authors.lastname: Martelli
mesh_terms: D000293:Adolescent; D000328:Adult; D000818:Animals; D016026:Bone Marrow Transplantation; D002648:Child; D004307:Dose-Response Relationship, Radiation; D005500:Follow-Up Studies; D006085:Graft Survival / Q000528:radiation effects; D006801:Humans; D007111:Immunity, Cellular / Q000528:radiation effects*; D007938:Leukemia / Q000628:therapy; D008223:Lymphoma / Q000628:therapy; D008297:Male; D051379:Mice; D008875:Middle Aged; D011879:Radiotherapy Dosage; D014916:Whole-Body Irradiation / Q000009:adverse effects / Q000401:mortality